Drug intelligence / Profile preview

uridine triphosphate

Development stage
Phase 3
Modality
Small Molecules
Administration
Inhalation, Intravenous
01

Overview

Uridine triphosphate (UTP) is a pyrimidine nucleoside triphosphate composed of the base uracil linked to ribose and esterified with three phosphate groups at the 5′ position. It is a naturally occurring nucleotide that serves as a substrate for RNA synthesis during transcription and acts as an energy source or activator in various metabolic reactions, such as glycogen synthesis and galactose metabolism[4]. UTP is also an endogenous agonist of P2Y2 receptors on ciliated respiratory epithelium[3], where it can modulate ion transport and mucociliary clearance. Experimentally, it has been studied for its effects on smooth muscle contraction via depolarization mechanisms involving activation of cation currents and inhibition of ATP-sensitive potassium channels[6]. UTP has been investigated in the diagnosis of lung diseases, including lung cancer[1].

Brand names
UTP Solution
Other names
uridine 5'-triphosphateuridine-5′-triphosphate
02

Targets

P2RY2 (P2Y Purinoceptor 2)Pol I (RNA polymerase I)T7 RNAP (T7 RNA polymerase)Pol II (RNA polymerase II elongation factors)GalU (UDP-glucose pyrophosphorylase 2)P2RY6 (Purinoceptor P2Y6)

Beyond the preview

Go deeper on uridine triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on uridine triphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call